Responding to the National HIV/AIDS Strategy-setting the research agenda.
作者信息
Morin Stephen F, Kelly Jeffrey A, Charlebois Edwin D, Remien Robert H, Rotheram-Borus Mary J, Cleary Paul D
出版信息
J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):175-80. doi: 10.1097/QAI.0b013e318222c0f9.
Abstract
摘要
相似文献
1
Responding to the National HIV/AIDS Strategy-setting the research agenda.
J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):175-80. doi: 10.1097/QAI.0b013e318222c0f9.
2
A way forward: the National HIV/AIDS Strategy and reducing HIV incidence in the United States.
J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 2:S144-7. doi: 10.1097/QAI.0b013e3181fbcb04.
3
A SWOT Analysis of the Updated National HIV/AIDS Strategy for the U.S., 2015-2020.
AIDS Behav. 2016 Jan;20(1):1-6. doi: 10.1007/s10461-015-1193-9.
4
The HIV/AIDS epidemic in Brazil: three decades.
Cad Saude Publica. 2011;27 Suppl 1:S4-5. doi: 10.1590/s0102-311x2011001300001.
5
Highlights from the 2001 National Conference on African Americans and AIDS.
Surviv News (Atlanta Ga). 2001 Apr:6.
6
Lessons from Africa.
J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 2(Suppl 2):S141-3. doi: 10.1097/QAI.0b013e3181fbcb76.
7
Multidrug Resistant HIV Drug Lauded, But Clinical Foundation Not Very Deep.
Manag Care. 2018 Jun;27(6):31-33.
8
Can we treat our way out of HIV?
AIDS Res Hum Retroviruses. 2010 Jan;26(1):1-4. doi: 10.1089/aid.2009.0267.
9
HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
Science. 2006 Jul 28;313(5786):484-7. doi: 10.1126/science.313.5786.484b.
10
Drug substitution therapy: a new approach in preventing the spread of HIV/AIDS in Malaysia.
Trop Doct. 2008 Apr;38(2):109-10. doi: 10.1258/td.2007.070001.
引用本文的文献
1
Examining Interprofessional Collaboration across case managers, peer educators, and counselors in New York City.
Soc Work Public Health. 2021 May 19;36(4):448-459. doi: 10.1080/19371918.2021.1905131. Epub 2021 Apr 9.
2
PROMISE (Program Refinements to Optimize Model Impact and Scalability based on Evidence): a cluster-randomised, stepped-wedge trial assessing effectiveness of the revised versus original Ryan White Part A HIV Care Coordination Programme for patients with barriers to treatment in the USA.
BMJ Open. 2020 Jul 27;10(7):e034624. doi: 10.1136/bmjopen-2019-034624.
3
Cost-effectiveness of HIV care coordination scale-up among persons at high risk for sub-optimal HIV care outcomes.
PLoS One. 2019 Apr 25;14(4):e0215965. doi: 10.1371/journal.pone.0215965. eCollection 2019.
4
Identifying social and economic barriers to regular care and treatment for Black men who have sex with men and women (BMSMW) and who are living with HIV: a qualitative study from the Bruthas cohort.
BMC Health Serv Res. 2017 Jan 28;17(1):90. doi: 10.1186/s12913-017-2011-z.
5
Dual-Routine HCV/HIV Testing: Seroprevalence and Linkage to Care in Four Community Health Centers in Philadelphia, Pennsylvania.
Public Health Rep. 2016 Jan-Feb;131 Suppl 1(Suppl 1):41-52. doi: 10.1177/00333549161310S106.
6
Acceptance of the use of HIV surveillance data for care engagement: national and local community perspectives.
J Acquir Immune Defic Syndr. 2015 May 1;69 Suppl 1(0 1):S31-6. doi: 10.1097/QAI.0000000000000573.
7
Effectiveness of Circle of Life, an HIV-preventive intervention for American Indian middle school youths: a group randomized trial in a Northern Plains tribe.
Am J Public Health. 2014 Jun;104(6):e106-12. doi: 10.2105/AJPH.2013.301822. Epub 2014 Apr 22.
8
HIV infection and sexual risk among men who have sex with men and women (MSMW): a systematic review and meta-analysis.
PLoS One. 2014 Jan 30;9(1):e87139. doi: 10.1371/journal.pone.0087139. eCollection 2014.
9
HIV infection, aging, and immune function: implications for cancer risk and prevention.
Curr Opin Oncol. 2012 Sep;24(5):506-16. doi: 10.1097/CCO.0b013e328355e131.
10
Supporting the integration of HIV testing into primary care settings.
Am J Public Health. 2012 Jun;102(6):e25-32. doi: 10.2105/AJPH.2012.300767. Epub 2012 Apr 19.
本文引用的文献
1
The effect of expanded antiretroviral treatment strategies on the HIV epidemic among men who have sex with men in San Francisco.
Clin Infect Dis. 2011 Apr 15;52(8):1046-9. doi: 10.1093/cid/cir085.
2
A way forward: the National HIV/AIDS Strategy and reducing HIV incidence in the United States.
J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 2:S144-7. doi: 10.1097/QAI.0b013e3181fbcb04.
3
The cost-effectiveness of HIV prevention interventions for HIV-infected patients seen in clinical settings.
J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):e87-94. doi: 10.1097/QAI.0b013e318204123e.
4
The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States.
Ann Intern Med. 2010 Dec 21;153(12):778-89. doi: 10.7326/0003-4819-153-12-201012210-00004.
5
Implementation science for the prevention and treatment of HIV/AIDS.
J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1(Suppl 1):S27-31. doi: 10.1097/QAI.0b013e3181f9c1da.
6
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.
Lancet. 2010 Aug 14;376(9740):532-9. doi: 10.1016/S0140-6736(10)60936-1. Epub 2010 Jul 16.
7
Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC.
Clin Infect Dis. 2010 Aug 15;51(4):392-400. doi: 10.1086/655130.
8
Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco.
PLoS One. 2010 Jun 10;5(6):e11068. doi: 10.1371/journal.pone.0011068.
9
Potential and limitations of a 'test and treat' strategy as HIV prevention in the United States.
Int J Clin Pract. 2010 May;64(6):678-81. doi: 10.1111/j.1742-1241.2010.02381.x.
10
Addressing research priorities for prevention of HIV infection in the United States.
Clin Infect Dis. 2010 May 15;50 Suppl 3(Suppl 3):S149-55. doi: 10.1086/651485.
Zotero 插件